LacriJet® is FCI’s latest and exclusive preloaded and self-retaining monocanalicular nasolacrimal intubation indicated for epiphora, congenital nasolacrimal duct obstruction, and canalicular laceration. It consists of a single use injector handpiece into which a silicone tube is preloaded inside a metallic guide. LacriJet® has been specifically designed to reduce operating time in both the intubation phase and the removal of the device.

LacriJet® is first introduced into the nasolacrimal duct. Once in position, the sliding piston is retracted and the silicone intubation is released. It is maintained in place at the punctum by a plug-like fixation head. No nasal retrieval, knots or sutures are needed.

The 15 mm and 20 mm LacriJet® have been specifically designed for canalicular laceration repair to prevent future canalicular obstruction due to scar tissue formation.